Literature DB >> 31146811

Toward Early Diagnosis of Pulmonary Hypertension: Lessons From Oz.

Bradley A Maron1, Bradley M Wertheim2.   

Abstract

Entities:  

Keywords:  diagnosis; pulmonary hypertension; screening

Mesh：

Year:  2019        PMID： 31146811      PMCID： PMC6747056          DOI： 10.1016/j.jacc.2019.03.473

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  13 in total

Review 1.  The Relationship Between the Right Ventricle and its Load in Pulmonary Hypertension.

Authors:  Anton Vonk Noordegraaf; Berend E Westerhof; Nico Westerhof
Journal:  J Am Coll Cardiol       Date:  2017-01-17       Impact factor: 24.094

Review 2.  Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review.

Authors:  G Kovacs; A Berghold; S Scheidl; H Olschewski
Journal:  Eur Respir J       Date:  2009-03-26       Impact factor: 16.671

Review 3.  Diagnosis and treatment of secondary (non-category 1) pulmonary hypertension.

Authors:  Stuart Rich; Marlene Rabinovitch
Journal:  Circulation       Date:  2008-11-18       Impact factor: 29.690

Review 4.  Translational Advances in the Field of Pulmonary Hypertension. Focusing on Developmental Origins and Disease Inception for the Prevention of Pulmonary Hypertension.

Authors:  Bradley A Maron; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2017-02-01       Impact factor: 21.405

Review 5.  Definitions and diagnosis of pulmonary hypertension.

Authors:  Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

6.  Redefining pulmonary hypertension.

Authors:  Bradley A Maron; Evan L Brittain; Gaurav Choudhary; Mark T Gladwin
Journal:  Lancet Respir Med       Date:  2017-12-18       Impact factor: 30.700

7.  Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

Authors:  Bradley A Maron; Edward Hess; Thomas M Maddox; Alexander R Opotowsky; Ryan J Tedford; Tim Lahm; Karen E Joynt; Daniel J Kass; Thomas Stephens; Maggie A Stanislawski; Erik R Swenson; Ronald H Goldstein; Jane A Leopold; Roham T Zamanian; Jean M Elwing; Mary E Plomondon; Gary K Grunwald; Anna E Barón; John S Rumsfeld; Gaurav Choudhary
Journal:  Circulation       Date:  2016-02-12       Impact factor: 29.690

8.  Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.

Authors:  Nazzareno Galiè; Joan A Barberà; Adaani E Frost; Hossein-Ardeschir Ghofrani; Marius M Hoeper; Vallerie V McLaughlin; Andrew J Peacock; Gérald Simonneau; Jean-Luc Vachiery; Ekkehard Grünig; Ronald J Oudiz; Anton Vonk-Noordegraaf; R James White; Christiana Blair; Hunter Gillies; Karen L Miller; Julia H N Harris; Jonathan Langley; Lewis J Rubin
Journal:  N Engl J Med       Date:  2015-08-27       Impact factor: 91.245

9.  Diagnosis, Treatment, and Clinical Management of Pulmonary Arterial Hypertension in the Contemporary Era: A Review.

Authors:  Bradley A Maron; Nazzareno Galiè
Journal:  JAMA Cardiol       Date:  2016-12-01       Impact factor: 14.676

10.  Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension.

Authors:  Tufik R Assad; Bradley A Maron; Ivan M Robbins; Meng Xu; Shi Huang; Frank E Harrell; Eric H Farber-Eger; Quinn S Wells; Gaurav Choudhary; Anna R Hemnes; Evan L Brittain
Journal:  JAMA Cardiol       Date:  2017-12-01       Impact factor: 14.676
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.